DOCSLIB.ORG

Halal Positive List (Eng).Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Halal Positive List (Eng).Pdf Attachment of Decree Number: SK12/DIR/LPPOM MUI/VI/20 HALAL POSITIVE LIST OF MATERIALS Halal Positive List of Materials consists of non-critical materials, in terms of their halalness status, commonly used in processing industries. This material list was made based on the assessment of LPPOM MUI refer to the literature, abundance in nature, and consideration of commercially production scales. Companies that using materials listed in Halal Positive List of Materials will get advantages as follows: 1. In selection process of new materials, materials listed in Halal Positive List of Materials already get material approval from LPPOM MUI automatically prior to use. 2. In process of incoming material checking, materials listed in Halal Positive List of Materials does not require the suitability checking of the material name, manufacture's name and country of origin. 3. In product registration process, materials listed in Halal Positive List of Materials does not require supporting document. If the materials use trade name which is different with material name, the material specification document is still required. During the audit process, the auditor may check the supporting documents of material when necessary. In Halal Positive List of Materials, there is a description of materials that are prohibited from being used for food or cosmetics according to Indonesia Food and Drug Administration (BPOM) regulation (PERKA BPOM No. 07/2018 and PERKA BPOM No. 18/2015). So that it can be used as a reference for companies in order to meet regulations regarding the use of materials for products marketed in Indonesia. The "x" sign in the column Prohibited used based on BPOM Regulation indicates that the material is not allowed to be used for the mentioned product category. Page 3 of 156 Halal Positive List of Materials is given in the following table: Prohibited used based on CAS Chemical Name BPOM Regulation Foods Cosmetics 673-84-7 2,6-Dimethyl-2,4,6-Octatriene 91-57-6 2-Methylnaphthalene 1576-78-9 [(E)-Hept-3-Enyl] Acetate 7-Acetoxy-3,7-Dimethyl-Octa- 72214-23-4 1,3-Diene 2216-45-7 (4-Methylphenyl)Methyl Acetate 127-42-4 Methyl- Alpha-Ionone (E)-1-(2,6,6-Trimethylcyclohex- 7779-30-8 2-En- 1-Yl)Pent-1-En-3-One Trans-2-Methyl-2-Pentenoic 16957-70-3 Acid 10544-63-5 Ethyl Crotonate 2497-18-9 Trans-2-Hexenyl Acetate 22104-79-6 2-Nonen-1-Ol 133-37-9 DL-Tartaric Acid 600-14-6 Pentane-2,3-Dione 2548-87-0 (E)-Oct-2-Enal 689-67-8 Geranylacetone 3913-81-3 3-Heptylacrolein 2-Ethenyl-2-Methyl-5-Prop-1- 13679-86-2 En-2-Yloxolane 3-Ethyl-2-Hydroxycyclopent-2- 21835-01-8 En-1-One 1365-19-1 Epoxydihydrolinalool 79-77-6 Β-Ionone (2-Methoxyphenyl)Methyl 1331-83-5 Acetate 104-87-0 P-Tolualdehyde 1189-09-9 Trans-Methylgeranate 498-02-2 Apocynin (E)-1-(2,6,6-Trimethyl-2- 24720-09-0 Cyclohexen-1-Yl)-2-Buten-1One 100-42-5 Styrene 7786-44-9 Cis-2,6-Nonadien-1-Ol 900488-10-8 Cis-Jasmone 8013-90-9 Ionone Mixed Isomers 105-45-3 Methyl Acetoacetate Page 4 of 156 540-18-1 Pentyl Butyrate 1337-83-3 Trans-2-Undecenal 490-03-9 Diosphenol 33467-74-2 Cis-3-Hexenyl Propionate 2,6-Octadienoic Acid, 3,7- 13058-12-3 Dimethyl-,Ethyl Ester 95-41-0 2-Hexylcyclopent-2-En-1-One 18829-56-6 Trans-2-Nonenal 1331-81-3 4-Methoxybenzyl Alcohol 1708-82-3 Trans-3-Hexenyl Acetate (E)-1-(2,6,6-Trimethyl-1- 23726-91-2 Cyclohexenyl) But-2-En-1-One 105-67-9 2,4-Dimethylphenol 76649-25-7 Trans,Cis-3,6-Nonadien-1-Ol Alpha-Amyl Cinnamaldehyde- 68527-78-6 Methyl Anthranilate (Schiff Base) 39212-23-2 Whiskey Lactone 68378-13-2 2-Methoxy-3-Methylpyrazine 489-86-1 Guaiol 95-21-6 2-Methylbenzoxazole 1191-16-8 Prenyl Acetate 1-(2,6,6-Trimethylcyclohex-2- 43052-87-5 En-1-Yl)But-2-Enone 151-05-3 Dimethylbenzylcarbinyl Acetate 10032-13-0 Hexyl Isovalerate 105-68-0 Isoamyl Propanoate 75-18-3 Dimethyl Sulfide 928-97-2 Trans-3-Hexen-1-Ol 22047-25-2 1-Pyrazin-2-Ylethanone (E)-1-(2,6,6-Trimethyl-1- 23696-85-7 Cyclohexa- 1,3-Dienyl)But-2- En-1-One 21662-09-9 Cis-4-Decen-1-Al 67952-65-2 (Methylthio)Methylpyrazine 1576-95-0 (Z)-2-Penten-1-Ol 75-65-0 Tert-Butanol 123-79-5 Dioctyl Adipate 28069-72-9 (2e,6z)-Nona-2,6-Dien-1-Ol 2049-96-9 Pentyl Benzoate 638-49-3 Pentyl Formate N-Valeric Acid Cis - 3 - Hexen - 35852-46-1 1 Yl Ester Page 5 of 156 67883-79-8 Cis-3-Hexenyl Tiglate 7069-41-2 Trans-2-Tridecenal 140-10-3 Trans-Cinnamic Acid 10152-77-9 Methyl (E,Z)-1-Propenyl Sulfide 26896-48-0 Tricyclodecanedimethanol 19317-11-4 Farnesal 80-59-1 Tiglic Acid 2-Ethyl-3(5 Or 6)- 27043-05-6 Dimethylpyrazine 928-95-0 Trans-2-Hexen-1-Ol 3,3-Dimethyl-5-(2,2,3- 107898-54-4 Trimethylcyclopent-3-En-1- Yl)Pent-4- En-2-Ol (2e)-2-Heptylidenecyclopentan- 39189-74-7 1-One 4-(4-Methyl-3- 21690-43-7 Pentenyl)Cyclohex-3- Ene-1- Carbonitrile Undecylenic Aldehyde, Mixed 900112-45-8 Isomers 3142-72-1 2-Methyl-2-Pentenoic Acid (Z)-3-Hexen-1-Yl 3- 35154-45-1 Methylbutanoate 2847-30-5 2-Methoxy-3-Methylpyrazine 17511-60-3 Herbal Propionate 3,7-Dimethyl-Octa-2,6-Diene-1- 38237-00-2 Thiol 86460-54-0 2-Methyl-3-Hexanone-Oxime 7787-20-4 (1r,4s)-Fenchone 109-49-9 Allylacetone 31846-06-7 3-T-Butyl-Cyclohexylacetat 25485-88-5 Cyclohexyl 2-Hydroxybenzoate 2-Hydroxy-4- 131-57-7 Methoxybenzophenone 489-40-7 (-)-Α-Gurjunene (1e,6e,8s)-1-Methyl-5- Methylene- 23986-74-5 8-(1-Methylethyl)-1,6- Cyclodecadiene Cis-4- 13828-37-0 Isopropylcyclohexylmethanol Dl-4-Isopropenyl-1- 7705-14-8 Methylcyclohexene 409-02-9 Methylheptenone Page 6 of 156 15356-70-4 (+/-)-P-Menthan-3-Ol 91-20-3 Naphthalene x 589-18-4 4-Methylbenzyl Alcohol 126-91-0 (R)-Linalool 2,6,9,10-Tetramethyl-1- 71078-31-4 Oxaspiro[4.5]Deca-3,6-Diene 140-67-0 4-Allylanisole 2,6,6- 473-54-1 Trimethylbicyclo[3.1.1]Heptan- 2-Ol 3-Methylbutyl (E)-Undec-6- 12262-03-2 Enoate 39864-15-8 1-Acetyloxynonyl Acetate 121-79-9 Propyl Gallate 8021-39-4 Creosote, Wood 88-15-3 2-Acetylthiophene 72869-82-0 Lemongrass Terpenes 8011-48-1 Pine Tar 1-(4,7,7-Trimethyl-3- 62501-24-0 Bicyclo[4.1.0]Hept-4- Enyl)Ethanone 2057-49-0 4-(3-Phenylpropyl)Pyridine 32669-00-4 1-Cyclooct-3-Enylethanone Ethyl 2-Methyl-3- 888021-82-7 Sulfanylbutanoate 67019-89-0 2,6-Nonadiene Nitrile 1-Methoxy-2-Methyl-3- 120811-92-9 Phenylpropane 2-(4-Methylphenoxy) 67845-46-9 Acetaldehyde 2-(4-Tert-Butylphenyl) 3288-99-1 Acetonitrile [(E)-2-Phenylprop-1-Enyl] 37973-51-6 Acetate (Z)-2-Phenylprop-1-En-1-Yl 37973-52-7 Acetate 1-(3,3-Dimethyl-2- 66062-78-0 Bicyclo[2.2.1]Heptanyl) Ethanol ((3a,4,5,6,7,7a-Hexahydro-4,7- Methano-1h-Inden-5(Or 6)- 94248-38-1 Yl)Oxy) Acetaldehyde 2,2-Bis(3- 68555-28-2 Methylbutoxy)Ethylbenzene Page 7 of 156 [2,2-Bis[(3,7-Dimethyl-2,6- 67634-02-0 Octadienyl)Oxy]Ethyl]Benzene 68039-47-4 2-Propan-2-Yloxyethylbenzene 1-(1,2,3,5,6,7,8,8a-Octahydro- 68155-66-8 2,3,8,8-Tetramethyl-2- Naphthyl)Ethan-1-One 1-(2,4,4-Trimethyl-1-Cyclohex- 70266-48-7 2- Enyl)But-2-En-1-One 1-(2,4-Dimethylcyclohex-3-En- 69929-17-5 1-Yl)- 2,2-Dimethylpropan-1- One 950-33-4 1,1-Dimethoxycyclododecane 1,2,3,4,4a,5,6,7-Octahydro-2,5,5- 41199-19-3 Trimethyl-2-Naphthol 2-Ethyl-4,4-Dimethyl-1,3- 444880-09-5 Oxathiane 2-Cyclohexylhepta-1,6-Dien-3- 313973-37-4 One 70131-51-0 Geraniol Still Bottoms 72894-14-5 (2e)-2-Ethylideneundec-10-Enal 68141-27-5 Heptyl Undec-10-Enoate (Nz)-N-[1-(5- 65416-21-9 Bicyclo[2.2.1]Hept-2- Enyl)Ethylidene]Hydroxylamine 2-Cyclohexylidene-2- 10461-98-0 Phenylacetonitrile 95-63-6 1,2,4-Trimethylbenzene Dipentene, Fraction Of Terpene 68956-56-9 Hydrocarbons 134769-33-8 Trideca-3,12-Dienenitrile 61699-38-5 Cyclooctyl Methyl Carbonate 1-(Diethoxymethyl)-4- 2403-58-9 Methoxybenzene 2,9 -Dimethyl-6-Propan-2-Yl-1- 89079-92-5 Oxaspiro[4.5]Deca-3,9-Diene 2-Methyl-4-Phenyl-1,3- 33941-99-0 Dioxolane 5333-42-6 2-Octyldodecan-1-Ol 929253-05-4 6-Methoxy-2,6-Dimethyloctanal 1741-41-9 Isobutyraldehyde Diethyl Acetal Page 8 of 156 4744-08-5 1,1-Diethoxypropane 1,3-Dioxane, 5-Methyl-2-(2- 166301-22-0 Methylpropyl)-, Cis- 13487-27-9 1-Cyclohexylethyl Acetate 4-[(3e)-4,8-Dimethylnona-3,7- 38462-23-6 Dienyl]Pyridine 3209-13-0 3-Methoxy-5-Methylphenol 629-59-4 Tetradecane (2-Ethenyl-6-Methylhept-5- 68412-04-4 Enyl) Acetate 2,4-Dimethyl-2-(5,5,8,8- Tetramethyl- 6,7- 131812-67-4 Dihydronaphthalen-2-Yl)-1,3- Dioxolane Terpinyl Acetate (Isomer 8007-35-0 Mixture) 2-Methoxy-4- 5533-03-9 (Methoxymethyl)Phenol 2,6-Dimethyl-7-Octen-2-Yl 25279-09-8 Formate Cis-3-Hexenyl 2- 53398-85-9 Methylbutanoate Α,Α,6,6- 33885-52-8 Tetramethylbicyclo[3.1.1]Hept- 2-Ene- 2-Propionaldehyde 1-(1,2,3,4,6,7,8,8a-Octahydro- 68155-67-9 2,3,8,8-Tetramethyl-2- Naphthyl)Ethan-1-One 941-98-0 1'-Acetonaphthone 8,8-Dimethyl-2,3,4,5,6,7- 68991-97-9 Hexahydro- 1h-Naphthalene-2- Carbaldehyde 3,4,4-Trimethylcyclopentane- 33079-56-0 1,2- Dione 1-Cyclohexylethan-1-Yl 63449-88-7 Butyrate 1-(Cyclopropylmethyl)-4- 16510-27-3 Methoxybenzene 2-(2,6-Dimethylhepta-1,5- 66408-78-4 Dienyl)- 1,3-Dioxolane Page 9 of 156 93384-32-8 Opopanax (Resin) 2-Hydroxy-1,2- 9000-72-0 Diphenylethanone 8000-41-7 Terpineol 89-71-4 Methyl O-Toluate 2-(4-Methylcyclohex-3-En-1- 2153-28-8 Yl)Propan-2-Yl Butanoate 2-Methoxybenzoic Acid Ethyl 7335-26-4 Ester 2050-08-0 Pentyl 2-Hydroxybenzoate 2-(4-Methylcyclohex-3-En-1- 7774-65-4 Yl)Propan-2-Yl 2- Methylpropanoate 2-(4-Methylcyclohex-3-En-1- 80-27-3 Yl)Propan-2-Yl Propanoate Methyl 2,6,6-Trimethylcyclohex- 28043-10-9 2- Ene-1-Carboxylate 2445-72-9 Pentyl 2-Methylpropanoate 10482-56-1 (S)-(-)-Α-Terpineol 103-09-3 2-Ethylhexyl Acetate [(1r,2s,5r)-5-Methyl-2-Propan-2- 2623-23-6 Ylcyclohexyl] Acetate 10361-39-4 Benzyl Pentanoate 3,7-Dimethyloct-6-Enyl 10580-25-3 Hexanoate 68922-10-1 Citronellyl Isovalerate 1205-42-1 (+/-)-Cis-Carveol Acetate 2050-09-1 3-Methylbutyl Pentanoate 5137-52-0
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 9,168,397 B2 Amalric Et Al
    US009 168397B2 (12) United States Patent (10) Patent No.: US 9,168,397 B2 Amalric et al. (45) Date of Patent: Oct. 27, 2015 (54) POWDERY EMULSIFYING COMPOSITION A61Q 19/005; A61Q 1/02: A61K 8/92: OF ALKYL POLYGLYCOSIDES, USE A61K 8/34: A61K 8/602: A61K 8/022: THEREOF FOR PREPARING COSMETC A61K 8/60; A61K 8/062: A61K 8/604; EMULSIONS, AND METHOD FOR A61K 8/06; A61K 8/342: A61K 2800/412: PREPARING SAME BO1F17/0092 See application file for complete search history. (71) Applicant: SOCIETE DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC, (56) References Cited Paris (FR) U.S. PATENT DOCUMENTS (72) Inventors: Chantal Amalric, Blan (FR); Alicia Roso, Saix (FR); Agnes Gorce, 5,670471 A 9, 1997 Amalric et al. 5,888,482 A 3, 1999 Amalric et al. Marseille (FR) 5,958,431 A 9/1999 Brancq et al. 6,245,821 B1 6/2001 Bulcourt et al. (73) Assignee: SOCIETE DEXPLOITATION DE 6,268.400 B1 7/2001 Amalric et al. PRODUITS POUR LES 6,353,034 B1 3/2002 Amalric et al. INDUSTRIES CHIMIQUES SEPPIC, 6,488,946 B1 12/2002 Milius et al. Paris (FR) 6,723,774 B2 4/2004 Guntherberg et al. 2003/0105169 A1 6/2003 Lennon (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 FOREIGN PATENT DOCUMENTS U.S.C. 154(b) by 0 days. EP O992508 4/2000 FR 2756195 5, 1998 (21) Appl. No.: 14/278,908 FR 2784904 4/2000 FR 283O464 4/2003 (22) Filed: May 15, 2014 WO 92O6778 4f1992 WO 9513863 5, 1995 (65) Prior Publication Data WO 9637285 11 1996 WO 9637286 11, 1996 US 2014/O2554.57 A1 Sep.
    [Show full text]
  • Chapter 21 the Chemistry of Carboxylic Acid Derivatives
    Instructor Supplemental Solutions to Problems © 2010 Roberts and Company Publishers Chapter 21 The Chemistry of Carboxylic Acid Derivatives Solutions to In-Text Problems 21.1 (b) (d) (e) (h) 21.2 (a) butanenitrile (common: butyronitrile) (c) isopentyl 3-methylbutanoate (common: isoamyl isovalerate) The isoamyl group is the same as an isopentyl or 3-methylbutyl group: (d) N,N-dimethylbenzamide 21.3 The E and Z conformations of N-acetylproline: 21.5 As shown by the data above the problem, a carboxylic acid has a higher boiling point than an ester because it can both donate and accept hydrogen bonds within its liquid state; hydrogen bonding does not occur in the ester. Consequently, pentanoic acid (valeric acid) has a higher boiling point than methyl butanoate. Here are the actual data: INSTRUCTOR SUPPLEMENTAL SOLUTIONS TO PROBLEMS • CHAPTER 21 2 21.7 (a) The carbonyl absorption of the ester occurs at higher frequency, and only the carboxylic acid has the characteristic strong, broad O—H stretching absorption in 2400–3600 cm–1 region. (d) In N-methylpropanamide, the N-methyl group is a doublet at about d 3. N-Ethylacetamide has no doublet resonances. In N-methylpropanamide, the a-protons are a quartet near d 2.5. In N-ethylacetamide, the a- protons are a singlet at d 2. The NMR spectrum of N-methylpropanamide has no singlets. 21.9 (a) The first ester is more basic because its conjugate acid is stabilized not only by resonance interaction with the ester oxygen, but also by resonance interaction with the double bond; that is, the conjugate acid of the first ester has one more important resonance structure than the conjugate acid of the second.
    [Show full text]
  • Transport of Dangerous Goods
    ST/SG/AC.10/1/Rev.16 (Vol.I) Recommendations on the TRANSPORT OF DANGEROUS GOODS Model Regulations Volume I Sixteenth revised edition UNITED NATIONS New York and Geneva, 2009 NOTE The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. ST/SG/AC.10/1/Rev.16 (Vol.I) Copyright © United Nations, 2009 All rights reserved. No part of this publication may, for sales purposes, be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying or otherwise, without prior permission in writing from the United Nations. UNITED NATIONS Sales No. E.09.VIII.2 ISBN 978-92-1-139136-7 (complete set of two volumes) ISSN 1014-5753 Volumes I and II not to be sold separately FOREWORD The Recommendations on the Transport of Dangerous Goods are addressed to governments and to the international organizations concerned with safety in the transport of dangerous goods. The first version, prepared by the United Nations Economic and Social Council's Committee of Experts on the Transport of Dangerous Goods, was published in 1956 (ST/ECA/43-E/CN.2/170). In response to developments in technology and the changing needs of users, they have been regularly amended and updated at succeeding sessions of the Committee of Experts pursuant to Resolution 645 G (XXIII) of 26 April 1957 of the Economic and Social Council and subsequent resolutions.
    [Show full text]
  • Understanding Benzodiazephine Use, Abuse, and Detection
    Siemens Healthcare Diagnostics, the leading clinical diagnostics company, is committed to providing clinicians with the vital information they need for the accurate diagnosis, treatment and monitoring of patients. Our comprehensive portfolio of performance-driven systems, unmatched menu offering and IT solutions, in conjunction with highly responsive service, is designed to streamline workflow, enhance operational efficiency and support improved patient care. Syva, EMIT, EMIT II, EMIT d.a.u., and all associated marks are trademarks of General Siemens Healthcare Diagnostics Inc. All Drugs other trademarks and brands are the Global Division property of their respective owners. of Abuse Siemens Healthcare Product availability may vary from Diagnostics Inc. country to country and is subject 1717 Deerfield Road to varying regulatory requirements. Deerfield, IL 60015-0778 Please contact your local USA representative for availability. www.siemens.com/diagnostics Siemens Global Headquarters Global Siemens Healthcare Headquarters Siemens AG Understanding Wittelsbacherplatz 2 Siemens AG 80333 Muenchen Healthcare Sector Germany Henkestrasse 127 Benzodiazephine Use, 91052 Erlangen Germany Abuse, and Detection Telephone: +49 9131 84 - 0 www.siemens.com/healthcare www.usa.siemens.com/diagnostics Answers for life. Order No. A91DX-0701526-UC1-4A00 | Printed in USA | © 2009 Siemens Healthcare Diagnostics Inc. Syva has been R1 R2 a leading developer N and manufacturer of AB R3 X N drugs-of-abuse tests R4 for more than 30 years. R2 C Now part of Siemens Healthcare ® Diagnostics, Syva boasts a long and Benzodiazepines have as their basic chemical structure successful track record in drugs-of-abuse a benzene ring fused to a seven-membered diazepine ring. testing, and leads the industry in the All important benzodiazepines contain a 5-aryl substituent ring (ring C) and a 1,4–diazepine ring.
    [Show full text]
  • Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
    Project No. TREN-05-FP6TR-S07.61320-518404-DRUID DRUID Driving under the Influence of Drugs, Alcohol and Medicines Integrated Project 1.6. Sustainable Development, Global Change and Ecosystem 1.6.2: Sustainable Surface Transport 6th Framework Programme Deliverable 4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Due date of deliverable: 21.07.2011 Actual submission date: 21.07.2011 Revision date: 21.07.2011 Start date of project: 15.10.2006 Duration: 48 months Organisation name of lead contractor for this deliverable: UVA Revision 0.0 Project co-funded by the European Commission within the Sixth Framework Programme (2002-2006) Dissemination Level PU Public PP Restricted to other programme participants (including the Commission x Services) RE Restricted to a group specified by the consortium (including the Commission Services) CO Confidential, only for members of the consortium (including the Commission Services) DRUID 6th Framework Programme Deliverable D.4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Page 1 of 243 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Authors Trinidad Gómez-Talegón, Inmaculada Fierro, M. Carmen Del Río, F. Javier Álvarez (UVa, University of Valladolid, Spain) Partners - Silvia Ravera, Susana Monteiro, Han de Gier (RUGPha, University of Groningen, the Netherlands) - Gertrude Van der Linden, Sara-Ann Legrand, Kristof Pil, Alain Verstraete (UGent, Ghent University, Belgium) - Michel Mallaret, Charles Mercier-Guyon, Isabelle Mercier-Guyon (UGren, University of Grenoble, Centre Regional de Pharmacovigilance, France) - Katerina Touliou (CERT-HIT, Centre for Research and Technology Hellas, Greece) - Michael Hei βing (BASt, Bundesanstalt für Straßenwesen, Germany).
    [Show full text]
  • International Journal of Advanced Scientific and Technical Research
    International journal of advanced scientific and technical research Issue 5 volume 1, January-February 2015 Available online on http://www.rspublication.com/ijst/index.html ISSN 2249-9954 Degradation Studies on Bronopol in Oral Hygiene Formulations Jampala Balaji1*, N.K.Sarthchandra Prakash2, 3 Krishan Manaral R&D Department, The Himalaya Drug Company, Makali, Bangalore, India-562162. ABSTRACT This study investigated the decomposition of Bronopol and its degradation products how they produce Nitrosamines in oral hygiene products. Based on this study Bronopol was degradable in oral hygiene products which are containing aqueous medium, higher pH values (4 to10) and which are presented in higher temperatures and then gives formaldehyde, and nitro compounds. These nitro compounds are acting as a nitrosating agent and react with secondary amines then give Nitrosamines in the products. The degradation study was done by using determination of mass by LCMS and determination of formaldehyde content by Head-Space GC. These studies strongly demonstrate the Bronopol was degradable in aqueous medium and give formaldehyde and nitro compounds. Bronopol was not acting itself as a nitrosating agent and its degradation products act as a nitrosating agent. The products which are containing the secondary amines and the nitrosating agent then the Nitrosamines are formed in that product. Keywords: Bronopol, Degradation, Nitrosamines, Formaldehyde, Oral hygiene products. INTRODUCTION Bronopol is an organic compound also called as a 2-bromo-2-nitropropane-1, 3- diol (Molecular formula: C(Br)(NO2)(CH2OH)2). In cosmetics Bronopol is used as an antibacterial preservative to prevent spoilage due to microbial contamination [1]. Bronopol structure was shown in fig1.
    [Show full text]
  • Survey and Risk Assessment of Chemical Substances in Deodorants
    Survey and risk assessment of chemical substances in deodorants Suresh C. Rastogi & Gitte Hellerup Jensen National Environmental Research Institute Jeanne Duus Johansen National Allergy Research Centre Survey of Chemical Substances in Consumer Products, No. 86 2007 The Danish Environmental Protection Agency will, when opportunity offers, publish reports and contributions relating to environmental research and development projects financed via the Danish EPA. Please note that publication does not signify that the contents of the reports necessarily reflect the views of the Danish EPA. The reports are, however, published because the Danish EPA finds that the studies represent a valuable contribution to the debate on environmental policy in Denmark. Contents SAMMENFATNING 5 SUMMARY 7 1 INTRODUCTION 11 2 MARKET SURVEY AND PRODUCT SAMPLING 13 2.1 MARKET SURVEY 13 2.2 LEGISLATION 15 2.3 SAMPLING OF PRODUCTS AND CONTROL OF LABELLING 15 2.4 SELECTION OF PRODUCTS FOR ANALYSIS 18 3 ANALYSIS 19 3.1 MATERIALS 19 3.2 ANALYSIS 19 3.2.1 Sample preparation 19 3.2.2 Analysis of fragrance substances 19 3.2.3 Analysis of triclosan 20 4 RESULTS 21 5 RISK ASSESSMENT 27 5.1 DEODORANTS AND CONTACT ALLERGY 27 5.2 RISK ASSESSMENT – IN GENERAL 27 5.3 THE SELECTED FRAGRANCE SUBSTANCES 28 5.3.1 HYDOXYISOHEXYL 3-CYCLOHEXENE CARBOXALDEHYDE (HICC) 28 5.3.2 HYDROXYCITRONELLAL 32 5.3.3 ISOEUGENOL 33 5.3.4 CINNAMAL/CINNAMYL ALCOHOL 34 5.4 FARNESOL 35 5.5 COMMENTS CONCERNING OTHER FRAGRANCE SUBSTANCES 35 5.6 ALLERGEN LOAD OF FRAGRANCE SUBSTANCES 36 5.7 TRICLOSAN 36 6 DISCUSSION 38 7 REFERENCES 43 ANNEX 1 49 3 4 Sammenfatning Deodoranter anvendes dagligt af store dele af befolkningen og kan indeholde ingredienser, som visse duftstoffer og konserveringsmidler, der er hyppige år- sager til hudallergi.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,239,087 B1 Mao Et Al
    USOO6239087B1 (12) United States Patent (10) Patent No.: US 6,239,087 B1 Mao et al. (45) Date of Patent: May 29, 2001 (54) DETERGENT COMPOSITIONS (56) References Cited CONTAINING FRAGRANCE PRECURSORS U.S. PATENT DOCUMENTS AND THE FRAGRANCE PRECURSORS THEMSELVES 2,448,660 9/1948 Croxall et al. ....................... 568/600 2,490,337 12/1949 Croxall et al. ....................... 568/594 (75) Inventors: Hsiang Kuen Mao, Kobe (JP); Joseph 5,288,423 * 2/1994 Behan et al...... ... 252/174.11 Paul Morelli; Henry Cheng Na, both 5,447,644 9/1995 Guenin et al. ........................ 252/8.6 5,500,138 3/1996 Bacon et al. ......................... 510/102 of Cincinnati, OH (US); Robert Ya-Lin 5,500,154 3/1996 Bacon et al. ......................... 510/102 Pan, Kobe (JP); Mark Robert Sivik, 5,656,584 * 8/1997 Angell et al. ........................ 510/441 Fairfield, OH (US) 5,668,862 9/1997 Price et al. ........................... 568/594 (73) Assignee: The Procter & Gamble Company, 5,731,282 3/1998 Duquesne ............................. 510/423 Cincinnati, OH (US) OTHER PUBLICATIONS Rothman et al., “Enol Esters XVI: Enol Ethers in Synthe Notice: Subject to any disclaimer, the term of this sis”: Eastern Regional Research Laboratory, Philadelphia, patent is extended or adjusted under 35 Pennsyvania, pp. 376-377, (Jun. 1972). U.S.C. 154(b) by 0 days. Dejarlais et al., “Preparation of Some Ethyl Higher-Alkyl Appl. No.: 09/155,140 Acetals and Their Conversion to Vinyl Ethers': Northern (21) Regional Research Laboratory, Peoria, Illinois, pp. 241-243, (22) PCT Fed: Mar. 22, 1996 (May 1961). (86) PCT No.: PCT/US96/04060 * cited by examiner S371 Date: Sep.
    [Show full text]
  • PC22 Doc. 22.1 Annex (In English Only / Únicamente En Inglés / Seulement En Anglais)
    Original language: English PC22 Doc. 22.1 Annex (in English only / únicamente en inglés / seulement en anglais) Quick scan of Orchidaceae species in European commerce as components of cosmetic, food and medicinal products Prepared by Josef A. Brinckmann Sebastopol, California, 95472 USA Commissioned by Federal Food Safety and Veterinary Office FSVO CITES Management Authorithy of Switzerland and Lichtenstein 2014 PC22 Doc 22.1 – p. 1 Contents Abbreviations and Acronyms ........................................................................................................................ 7 Executive Summary ...................................................................................................................................... 8 Information about the Databases Used ...................................................................................................... 11 1. Anoectochilus formosanus .................................................................................................................. 13 1.1. Countries of origin ................................................................................................................. 13 1.2. Commercially traded forms ................................................................................................... 13 1.2.1. Anoectochilus Formosanus Cell Culture Extract (CosIng) ............................................ 13 1.2.2. Anoectochilus Formosanus Extract (CosIng) ................................................................ 13 1.3. Selected finished
    [Show full text]
  • USP Excipient Reference Standards Catalog
    Last Updated On: March 15, 2021 USP Excipient Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) 1002505 Acesulfame G0H082 F0C136 (30-JUN- 55589-62-3 N/A $410.00 Potassium (200 mg) 2009) 1005706 Glacial Acetic Acid R038A0 I0M342 (31-JUL- 64-19-7 N/A $280.00 (1.5 mL/ampule; 3 2017) ampules) 1006801 Acetone (1.5 R095B0 I0M548 (28-FEB- 67-64-1 N/A $265.00 mL/ampule; 3 2022) ampules) 1009005 Acetylcysteine (200 R10200 K0K294 (30- 616-91-1 N/A $245.00 mg) NOV-2019) 1009901 Acetyltributyl Citrate R053A0 H0I337 (31-AUG- 77-90-7 N/A $275.00 (3 x 200 mg) 2017) 1009923 Acetyltriethyl Citrate R041M0 H0I339 (31-JAN- 77-89-4 N/A $275.00 (500 mg) 2017) 1012190 Adipic Acid (100 mg) F1D318 F0D318 (31- 124-04-9 N/A $265.00 MAR-2018) 1012214 Agar (500 mg) F0K137 N/A N/A $253.00 1012595 rAlbumin Human (6 R04600 G0M268 (31- N/A N/A $314.00 Cold Shipment mg) (Recombinant DEC-2016) Required Human Albumin) (COLD SHIPMENT REQUIRED) 1012688 Alcohol R05900 G0M024 (31- 64-17-5 N/A $265.00 Determination-- OCT-2018) Alcohol (5 Page 1 Last Updated On: March 15, 2021 USP Excipient Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) mL/ampule; 5 ampules) 1012768 Alcohol (1.2 R127S0 R087W0 (31- 64-17-5 N/A $245.00 mL/ampule; 5 MAY-2020) ampules) 1012772 Dehydrated Alcohol R119J0 G0M292 (31- 64-17-5 N/A $245.00 (1.2 mL/ampule; 5 MAY-2020) ampules) 1012799 Aleuritic Acid (50 F02300 533-87-9 N/A $278.00 mg)
    [Show full text]
  • Calculating Equivalent Doses of Oral Benzodiazepines
    Calculating equivalent doses of oral benzodiazepines Background Benzodiazepines are the most commonly used anxiolytics and hypnotics (1). There are major differences in potency between different benzodiazepines and this difference in potency is important when switching from one benzodiazepine to another (2). Benzodiazepines also differ markedly in the speed in which they are metabolised and eliminated. With repeated daily dosing accumulation occurs and high concentrations can build up in the body (mainly in fatty tissues) (2). The degree of sedation that they induce also varies, making it difficult to determine exact equivalents (3). Answer Advice on benzodiazepine conversion NB: Before using Table 1, read the notes below and the Limitations statement at the end of this document. Switching benzodiazepines may be advantageous for a variety of reasons, e.g. to a drug with a different half-life pre-discontinuation (4) or in the event of non-availability of a specific benzodiazepine. With relatively short-acting benzodiazepines such as alprazolam and lorazepam, it is not possible to achieve a smooth decline in blood and tissue concentrations during benzodiazepine withdrawal. These drugs are eliminated fairly rapidly with the result that concentrations fluctuate with peaks and troughs between each dose. It is necessary to take the tablets several times a day and many people experience a "mini-withdrawal", sometimes a craving, between each dose. For people withdrawing from these potent, short-acting drugs it has been advised that they switch to an equivalent dose of a benzodiazepine with a long half life such as diazepam (5). Diazepam is available as 2mg tablets which can be halved to give 1mg doses.
    [Show full text]
  • Of 8 August 2014 Amending Annexes III, V and VI to Regulation (EC) No 1223/2009 of the European Parliament and the Council on Cosmetic Products
    9.8.2014 EN Official Journal of the European Union L 238/3 COMMISSION REGULATION (EU) No 866/2014 of 8 August 2014 amending Annexes III, V and VI to Regulation (EC) No 1223/2009 of the European Parliament and the Council on cosmetic products (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (1), and in particular Article 31(2) thereof, Whereas: (1) The substances identified by the denominations alkyl (C12-22) trimethyl ammonium bromide and chloride are regu­ lated as preservatives under entry 44 of Annex V to Regulation (EC) No 1223/2009 with a maximum concentra­ tion of 0,1 %. (2) The Scientific Committee on Consumer Products (‘SCCP’), subsequently replaced by the Scientific Committee on Consumer Safety (‘SCCS’) pursuant to Commission Decision 2008/721/EC (2), evaluated the safety of alkyl (C16, C18, C22) trimethylammonium chloride (cetrimonium chloride, steartrimonium chloride and behentrimonium chloride) for other uses than as preservatives in 2005, 2007 and 2009. (3) The SCCS concluded in its opinion of 8 December 2009 (3) that, apart from the fact that quaternary ammonium derivative formulations have the potential to be skin irritants, especially when combinations of the concerned compounds are used, the use of cetrimonium chloride, steartrimonium chloride and behentrimonium chloride does not pose a risk to the health of the consumer in concentrations below certain limits, which are explicitly set out in the SCCS opinion.
    [Show full text]